Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects

Conditions:   Symptomatic Neurogenic Orthostatic Hypertension;   nOH Interventions:   Drug: Ampreloxetine ;   Drug: Ampreloxetine ;   Drug: Ampreloxetine Placebo;   Drug: Moxifloxacin;   Drug: Moxifloxacin Placebo Sponsor:   Theravance Biopharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials